Bevacizumab is active as a single agent against recurrent malignant gliomas.
Agha
Caroline A
CA
The University of Alabama at Birmingham, Department of Neurology, Birmingham, AL, USA.
Ibrahim
Saman
S
Hassan
Ahmed
A
Elias
Dean A
DA
Fathallah-Shaykh
Hassan M
HM